Blog

Three Ways the Direct-to-Patient Site Model Creates Value for Dermatologic Clinical Trials

Author: Robert Stavert, M.D., M.B.A, Medical Director, Dermatology, Science 37 The past decade has brought…

Blog

Treated Like a Human, Not a Statistic

Virtual clinical trial access program provided breast cancer patients with personal, in-home treatment during the…

Blog

A Conversation with Freenome and Jonathan Cotliar, M.D., Chief Medical Officer, Science 37

In a few words, what is Science 37 and what is the benefit of decentralized…

Report

How to Save an At-Risk Clinical Trial

How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research…

Blog

Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research

Author: Debra Weinstein, MD, Vice President - Internal Medicine Virtual sites can help deliver infectious…

Blog

4 Things to Know about the EMA’s Updated Decentralized Clinical Trial Recommendations

Authors: Jen Davis, Deputy General Counsel & Chief Privacy Officer and Silvia Chia, Senior Director…

Blog

Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 & Beyond

Author: Dr. Shaalan Beg, Vice President, Oncology Oncology is a therapeutic area of singular importance…

Blog

What Clinical Trial Patient Participants Want

Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials, participant satisfaction is critical…

Report

Clinical Decision Makers Confirm a Shift to Hybrid and Decentralized Studies

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials?…

Webinar

Decentralization in Action: What Oncology Trials Look Like Now

What current clinical research looks like with oncology trials

Webinar

What Clinical Trial Participants Want — And How Sponsors can Deliver

Science 37 carefully examines all clinical trial options and elements needed for research — helping…

Report

Decentralized Clinical Trials — Is There a Positive Return on Investment on a Virtual Site?

Across the Life Sciences industry, there has been much talk about the cost and value…